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ON THE HILL

Scarupa: Kidney Transplantation: Beacon of Hope

By Harriet Jackson Scarupa

or 10 years and 3 months now
Scottie Leftdwrige has been
walking around with the kidney
of a dead stranger implanted in
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his body.
The 45-year-old Howard University
Hospital medical aide is the first person to
have received a kidney transplant from
the hospital’s transplant center.
His transplant followed a period when
he was so weak he couldn’t walk two
blocks without stopping to rest, when his
weight dropped alarmingly because he
was unable to keep food in his stomach,
when his urine was tainted with blood, his
heartbeat irregular, his whole body
wracked by nausea. One night, when the
nausea drove him nearly out of his mind,
he sought out a doctor. The diagnosis:
kidney failure.
When kidneys fail because of disease,
damage, or some congenital abnormality,
the body does not excrete enough water,
salt and other substances. This causes
the volume of water in the body to in
crease and tissues to swell. Without med
ical intervention— dialysis or a transplant
— the composition of body fluids will
change steadily until it becomes so ab
normal that death will ensue.
For 10 months Leftdwrige was on
dialysis — a time-consuming process of
cleansing the blood through an artificial
kidney machine. When the nephrologist
[kidney specialist] who was treating him
suggested he consider a transplant,
Leftdwrige was frightened by the idea of
an operation at first. But when he consid
ered the alternative— being hooked up to
a dialysis machine for 12 or more hours a
week and then still feeling weak much of
the time, having to make do on a severely
restricted diet, not even being able to
drink a glass of water whenever he felt
like it — he decided to chance the opera
tion. “I just wanted to get better,” he
recalls.
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He did get better. Much better. Two
weeks after the transplant, he was dis
charged from the hospital. Gradually his
strength returned. Gradually he was able
to resume working, though in a new job in
the central supply section of the hospital
instead of in his old job at a laundry. Today,
he says, except for not being able to lift
heavy objects, he can do just about every
thing he could before kidney disease
struck him down.
Recently Leftdwrige participated in a
group therapy session which the Howard
transplant center runs for past, present
and future transplant recipients. As the
session began, the nurse leading it asked
the patients to share some of their posit
ive thoughts of the day. When it was
Leftdwrige’s turn, the soft-spoken, re
served father of six willingly obliged: T m
thankful for being able to work, for being
able to do things I couldn’t do on the
[dialysis] machine. I’m thankful my appe
tite’s much better and that I don’t have as
much sickness. I’m thankful I’m able to
live a normal life. ”
Scottie Leftdwrige’s experience repre
sents the up side of the kidney transplan
tation story. So do the experiences of
many of the center’s other patients. Peo
ple like Vernita Howard, who’s had “her”
kidney for nine years now, she proudly
tells you, and even more proudly tells you
that she’s been able to give birth to a
healthy child. Or Ronald Norris, who re
ceived a transplant eight years ago and
later went on to win first place in the
150-meter run at a special Olympics in
Athens, Greece, for transplant patients
from all over the world. Or Alvin Brown, a
three-time kidney recipient, who founded
a group to help make the hospital stays of
low-income transplant patients more
comfortable and to educate the larger
public about kidney disease and trans
plantation. Or Tomeka Batey, who was
transformed from a listless invalid to an
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Scottie Leftdwrige (left), the first person to receive a transplant from the Howard transplant center with
Reather Felton, head nurse of the Howard University Hospital’s dialysis unit.

active schoolgirl after she received a kid
ney from her mother six months ago.
[See Box, “A Mother’s Story.”]
But there’s another side to the trans
plantation story. The down side. A week
after Leftdwrige shared his blessings
about being able to live a normal life in
that meeting room on the hospital’s fourth
floor, another kind of drama was taking
place in a basement intensive care unit.
There 27-year-old Denise Chasten, who
made medical history in October 1982 by
being the first woman with sickle cell dis
ease and a kidney transplant to have a
baby, had just been admitted as a patient.
She was lying on a bed hooked up to a
dialysis machine while an electrocardiog
raph was monitoring her heart and new
entries were rapidly being penned on her
medications chart. Her manner was
lethargic, her breathing labored, her
jowls heavy with excess fluid.
Denise Chasten was in the midst of a
rejection episode, her body reacting to
her transplanted kidney— the second one
she’d received in three years — as if it
were some hostile foreign invader that
must be attacked. The rejection action
had caused the potassium level in her
bloodstream to shoot up and if the pre

scribed medication wasn’t able to bring it
down, her heart could be endangered.
Her condition: critical.
Two sides of the same sto ry . . . Yes,
kidney transplantation offers the dazzling
promise of a better quality of life to those
whose own kidneys have failed. In fact,
since the first successful transplant was
performed in 1954 on identical twins at
Peter Bent Brigham Hospital in Boston,
Mass., thousands of transplant opera
tions have been done with increasing
rates of success.
But kidney transplantation isn’t always
the answer. Sometimes it doesn’t work
and even when it does work there is the
ever-present threat of rejection and the
often troublesome side effects from the
drugs recipients must take to prevent
that rejection.
Who Decides?
“All I do with patients is give them the
pros and the cons,” says Dr. Clive
Callender, the noted transplant surgeon
who serves as director of the Howard
University Hospital Transplant Center. “I
don’t tell anyone, ‘You must have a trans
plant. ’ I say, T hese are the pros. These
are the cons. What do you want?”’
2
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Since 1974, Howard’s center
has performed about 160
transplants...

The patients attending that group
therapy session seemed united in their
view that they would willingly undergo
one, two, even more transplants, if nec
essary, if it meant freedom from that
dreaded [dialysis] machine. (A social
worker assigned to the center points out
that there are also patients who do well on
dialysis and who choose to continue this
mode of treatment even if they would be
good transplant candidates.) “The mortal
ity rate for patients who have transplants
is about the same as for those on
dialysis/’ Dr. Callender says. “The big
difference is that the quality of life after
transplantation is generally so improved.”
A further note on the mortality ques
tion: Previously the average life span of a
person on dialysis was considered to be
10 years. But with improvements in the
procedure, that life span has been ex
tended significantly. Those involved in
treating patients who are on dialysis or
have transplants shy away from making
any blanket predictions about how long
such patients will be able to live, pointing
out that so much depends on individual
variables — a person’s overall health be
fore being struck with kidney disease,
conscientious adherence to doctor’s or
ders, heredity, lifestyle, will to live . . .
Some people on dialysis or with a trans
plant have lived for years and years,
others for weeks.
The allure of being able to enjoy an en
hanced quality of life helps explain why
the number of patients in the nation await
ing transplants continues to exceed the
number of available organs. The general
thinking among many involved in trans
plantation is that 30 percent of all patients
who are on dialysis are potential candi
dates for transplantation. As for the pres
ent state of affairs: A report prepared by
the Forum of Network Coordinating
Councils, which facilitates the exchange
of information among the nation’s end

stage renal disease networks, noted that
in 1982 [the most recent year for which it
released figures] there were 5,358 trans
plants performed in the nation’s trans
plant centers, while 6,720 people were on
transplant center waiting lists. Of the
total transplants performed that year,
3,681 of the kidneys came from cadavers,
i.e. from people who recently had died,
while 1,677 came from living relatives of
patients.
Donations from living relatives have a
much higher success rate than those from
cadavers. A National Kidney Foundation
publication points out that when the
transplanted kidney comes from a closely
matched brother or sister, for example,
the long-term chances of that kidney
functioning are about 90 percent. When
the kidney comes from an unrelated dead
person — as is still the case with most
kidney transplants — the success rate
drops to between 50 and 60 percent two
years after the transplant. (Comprehen
sive statistics are not kept for a longer
period.)
Since Scottie Leftdwrige’s transplant
on January 28, 1974, Howard’s center has
performed about 160 transplants, with
about 20 percent of these involving dona
tions from relatives — with none of the
donors experiencing any problems.
Of those patients who received trans
plants at Howard, 50 percent are still alive
with functioning kidneys, 25 percent have
returned to dialysis, while the other 25
percent have died from causes related di
rectly or indirectly to kidney problems.
Dr. Callender shares these figures, then
goes on to add a pointed footnote: “I think
our statistics compare with the national
averages. But I don’t deal with that issue
[of comparisons]. It’s like comparing ap
ples and oranges because most centers
have predominantly white patients and
our patients are Black. ”
As he had testified last October before

a Senate committee holding hearings on a
proposed organ transplant bill:
“Blacks who suffer from end stage
renal disease and who require dialysis and
transplantation are a unique group who
appear to do poorer after transplantation
than whites or other minority groups.
The reasons for this are unclear but may
relate to the fact that American Blacks are
disadvantaged from the cradle to the
grave for the following reasons:
“1. They are born weighing less than
whites.
2. They have twice the infant mortality
rate of whites.
3. Their life span is 4-5 years shorter
than whites.
4. They have hypertension 3-4 times as
frequently as whites.
5. They suffer end stage renal disease
from hypertension 17 times as fre
quently and end stage renal disease,
in general, four times as frequently as
their white counterparts.”
Among some of the other facts he
shared during his testimony: that 70 per
cent of the patients who are on dialysis in
the southeastern part of the United
States are Black; that Blacks do 10-20
percent poorer after transplantation than
whites; that the District of Columbia,
with its 70 percent Black population, has
the highest incidence of renal disease in
the United S ta te s .“These shocking
facts,” he emphasized, “indicate that
Blacks suffering from end stage renal dis
ease require special treatment and are a
population that must be listened to.”
The Howard Center
The Howard University Hospital Trans
plant Center is the only transplant center
in the nation affiliated with a predomi
nantly Black university. And the special
population it serves — of whom and for
whom Dr. Callender spoke so forcefully
during that testimony — has shaped not
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only the center’s approach to kidney
transplants but the role it has carved out
for itself in the larger medical-socio
political community.
The center dates back to 1970 when
Dr. LaSalle Leffall, chairman of the de
partment of surgery of what was then
Freedmen’s Hospital, suggested that Dr.
Callender, who had been chief resident in
surgery the previous year, apply for a
special postdoctoral fellowship in trans
plant immunology at the University of
Minnesota, a national leader in organ
transplantation. Dr. Callender received
the fellowship, spending two years under
the tutelage of noted transplant surgeon
Dr. John Najarian, and returned to How
ard in 1973 to launch a transplant center
[See Box: “God Should Have the Glory.”]
In November 1975, following a con
certed lobbying effort, Howard’s center
received certification from the Depart
ment of Health, Education and Welfare,
thus making it eligible to receive federal
reimbursement for transplant operations.
(A typical transplant, including pre- and
post-operative hospital care, costs about
$20,000; complicated cases run much
higher. Thanks to special legislation,
most kidney transplants are now covered
by Medicare.)
Through the years, the center has
been able to tally up some important
achievements:
■ It was the first transplant center in the
Washington area to use the drug an
tilymphocyte globulin (ALG) to re
verse kidney rejection and the second
in the nation to experiment with total
lymphoid irradiation as an anti-rejec
tion treatment.
■ It has shown remarkable success in
transplanting and rehabilitating a group
of patients many hospitals dismiss as
hopeless — heroin addicts — and has
innovated in the use of group therapy
for all its patients.
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■ It has conducted research in such areas
as pancreatic transplants, organ pres
ervation and the pretreatment of kid
neys with ALG and has helped medical
students, interns and residents be
come more knowledgeable about
transplantation.
■ It has played a small but significant role
in enlarging the pool of the nation’s
Black transplant surgeons. (Consider,
for example, the fact that only three of
the 303 members of the prestigious
American Society of Transplant Sur
geons are Black.) Dr. Joel Stevens, the
center’s assistant director, was trained
in transplant surgery both at Howard
and the University of Minnesota. He
has been followed by Dr. Jock Simon,
currently receiving special training in

kidney, liver and pancreatic transplants
at the University of Minnesota. He is
expected to rejoin the staff of the How
ard center in May.
■ It also has extended its training and
treatment efforts beyond the continen
tal United States. (Since October
1982, the Howard center has been in
volved in training a medical team in the
U.S. Virgin Islands to do kidney .trans
plants. The first transplant the joint
Howard-St. Thomas Hospital medical
team performed on the islands on De
cem ber 14, 1982 received major
coverage in St. Thomas newspapers
and on television and was hailed by the
governor as heralding “a new plateau in
the quality of health care now available
in the Virgin Islands.” In dedication
4
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gether all aspects of the center’s work;
secretaries (Loyce Battle and Thelma
Washington) who take care of its detailed
paperwork. Working closely with the staff
of the transplant center are nephrologists
(Drs. Adrian Hosten, Martin Dillard and
Iluminado Cruz) who recommended pa
tients for transplant and care for them
when they are on dialysis.

ceremonies in February 1983, St.
Thomas Hospitals new transplant cen
ter was named after Dr. Clive
Callender. As of this writing, the cen
ter had performed six kidney trans
plants, with all but one still functioning.
Plans call for the Virgin Islands trans
plant team to be completely autono
mous in two years.)
Given the center’s accomplishments
and given the national reputation it has
earned, few on the Howard campus were
surprised in April 1982 when it received
the university’s Outstanding Achieve
ment Award in the Division of Health Sci
ences.
As an organizational entity, the trans
plant center serves as the surgical arm of
Howard University Hospital’s renal unit.
Published by Digital Howard @ Howard University,

As a physical entity, it consists of various
offices, laboratories, treatm ent and
operating rooms within the hospital. But
the center is also people, people who
work together as a team. It is transplant
surgeons (Drs. Callender and Stevens.) It
is surgeons with other specialties (Dr.
Aaron Jackson, a urologist who heads the
team operating on kidney donors; Dr.
Oswald Warner, a specialist in vascular
access, i.e. providing a connection be
tween artery and vein, a preliminary step
that is necessary for hemodialysis). It is
specialized nurses (Josephine Flores and
Patricia Dillard); a social worker (Earlene
Reavies); a dietician (Sylvester White); a
perfusionist (Rodney Smith) who is in
charge of organ preservation; a transplant
coordinator (Curtis Yeager) who pulls to

11

The Surgical Procedure
When a dialysis patient is deemed suita
ble for a transplant and he or she wants a
transplant, the center’s mechanisms start
rolling. Transplant coordinator Yeager
explains how:
Family members of the patient are
brought together to see if any of them
would be willing to donate a kidney. If so,
they are tested to see if their blood and
tissues are compatible with those of the
patient. The best donor in the family is
then identified, someone who not only
has compatible blood and tissues, but is
also in good general health. If that person
decides to donate, the case is scheduled,
patient and donor are m atched and
brought into the hospital for the actual
operation. (Having just one kidney gen
erally causes no particular problems be
cause one kidney is able to do all the work
of two. Some people, in fact, are born
with one kidney.)
If no relatives are willing or able to do
nate a kidney, information about the pa
tient’s blood and tissue type is put on a
computer listing which goes out all over
the country in hope that somewhere a
compatible kidney will be found from
someone who recently has died and had
agreed to organ donation. (The ideal
donor would be someone who had been in
good health but died suddenly — from a
gunshot wound or in a car accident, for
instance.) Once a suitable kidney is lo
cated, the hospital in question is informed
of the Howard center’s need for it and
NEW DIRECTIONS APRIL 1984
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transportation is arranged. Here, time is
of essence. A kidney removed from a
cadaver will only be good for transplanta
tion for 37 hours (when packed in ice) or
72 hours (when put in a special renal
preservation machine.)
The actual operation varies depending
on whether the kidney comes from a
cadaver or a living relative. Dr. Joel Ste
vens gives the highlights of a typical 4-6
hour donor-recipient operation:
An incision is made, usually on the re
cipient’s right lower abdomen, and the
large blood vessels are exposed just
above the thigh. At the same time, the
donor is being operated on in an adjoining
room. The donor operating team takes
out a kidney, the one that previously has
been identified as best for transplant,
closes up the spot from which the kidney
has been removed and closes up the ab
domen.
Meanwhile, with great care, the recip
ient operating team hooks up the kidney
in this manner: The vein of the donor kid
ney is attached (using sutures) to one of
the large veins that has been exposed and
similarly the artery of the kidney is at
tached to the artery that has been ex
posed. Then the recipient’s bladder is ex
posed and hooked up to the ureter of the
donor kidney. The abdomen is then
closed, completing the surgical proce
dure. Generally, the transplanted kidney
starts working immediately.
In some cases, a surgeon will have re
moved the recipient’s old kidneys in an
earlier operation, in other cases they
would have been left in, depending on in
dividual circumstances.
During surgery, the greatest risks to
the transplant recipient come from any
adverse reactions to the anesthetic and
from excessive bleeding, Dr. Stevens
points out. After the operation, the
biggest threats become infection and re
jection, although sometimes bleeding still
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Feeling helpless as you r child wastes away before you r very
eyes is undoubtedly the greatest torm ent a parent can en
dure. H ere D oris Dotson, a N ashville mother, speaks o f her
daughter Tomeka’s struggle with kidney disease and the
road both o f them took so that Tomeka could have a more
norm al life. H er’s is a story o f pain and anger, o f courage
and hope.
t the age of four, Tomeka—
who had always been tiny—
seem ed to be gaining a little
weight. Suddenly one night
her whole abdomen sort of swelled up
and we took her to the emergency
room and her pediatrician called in a
nephrologist. At the time it was de
term ined that she did, in fact, have a
kidney problem: protein was spilling
through her urine and causing her body to swell. It was called
nephrotic syndrome. For two years, while she was on medication
for that, we were hoping and praying the problem would go away.
Instead, it turned worse. Christmas 1982 her kidneys totally
failed.
She was put on peritoneal dialysis, the quickest and shortest
kind of dialysis, because it was determ ined that my tissues were
compatible and I could donate a kidney to her for a transplant. No,
I wasn’t frightened to give up a kidney — even though a lot of
people tried to talk me out of it. They said, ‘Why would you
endanger your own life?’ and ‘Why don’t you just wait for a kidney
to come, a cadaver kidney?’ and ‘Shouldn’t you think about your
own health, after all, you have two other children?’ and things like
that. But I didn’t want to hear those kinds of things. The only thing
that did frighten me was that my baby was so ill and I couldn’t help
her. When I found out I could help her [by donating a kidney],
there was no question in my mind about what I would do.
Since February [’83] we had been in consultation with a white
doctor at Vanderbilt Hospital about having the operation. I was
under the impression we would get a kidney transplant about May
because I work with the school system [as a teacher’s assistant
for handicapped children] and I wanted to have enough time to
recuperate before school started. Around July 1st I still hadn’t
heard anything and I was getting w orried because soon it would
be time for me to go back to work and also because Tomeka w asn’t
doing any better. Also, by this time, with the worrying and all, I
had picked up some weight. So this white doctor said that I was
overweight and that he couldn’t do the surgery— even though he

A
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had never tested me or even gotten a history of my health or
anything! — and that Tomeka would have to go on hemodialysis.
On the day she was being operated on to get the fistula [a
surgical joining of artery and vein beneath the skin done so that
hemodialysis can take place] I really shrilled out. I just got so
distraught because I couldn’t go through seeing her go through
hemodialysis, couldn’t see her being a slave to that machine. That
same day someone had told us that there was a kidney center up at
Howard University. While Tomeka was still in surgery, my hus
band called Mr. Yeager [Curtis Yeager, transplant coordinator for
the Howard center] and told him about our situation, telling him
how my weight problem was supposed to be the reason for the
holdup of the transplant here. Mr. Yeager said he and Dr. [Clive]
Callender were supposed to be at a conference in Nashville in
about two weeks and would be glad to look at us.
They came and when they saw me, they laughed. They said
they were looking for a lady three feet tall and three feet wide.
They said I didn’t seem to have a weight problem as far as they
w ere concerned. The next day they went to Tomeka’s doctor’s
office and they examined her and told me how terrible she looked
and asked why anyone would wait to do the surgery. Later I
learned that when they w ere talking among them selves outside
the clinic doors they said that Tomeka wasn’t going to make it very
long [without a transplant], that she was, in fact, dying. Dr.
Callender asked me if I was still ready to have the surgery. I told
him, ‘Yes.’ He said, ‘How soon can you come?’ So, naturally, I
said, ‘Two or three weeks. ’ He said, ‘No, I’m not even going to ask
you. Be there next week. ’
So we w ent and stayed up there at Howard University Hospital
21 days. The date of the operation was Septem ber 16,1983. The
hospitality of the patients and the w orkers and the medical attend
ants really helped me a lot to not be afraid. It was the first time I’ve
ever been in an experience where the medical people themselves
actually presented God as some type of strength for me to hold
onto. And this is a big part of what gave me confidence in Dr.
Callender because he told me that he could do 150 percent and
God would have to do the rest. And I really liked that. Because I
think you have to believe. I’m serious. It really does hel p. . . .
Since the operation w e’re both doing great. Tomeka’s on a few
medications, two of them she’ll have to take for the rest of her life
or the life of the kidney. She had to learn her medications and
dosages and she does well with them. We put her medications in a
little case and she takes them with her to school.
Tomeka turned seven last October 30th. Before the surgery,
she was listless and didn’t want to do anything. Since the surgery,
she’s had a 360 degree turnaround. She’s able to play now. She
does real well in school and has made the principal’s honor roll.
Before, she was sick every day, every day. Now, she’s really
enjoying life.
□
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can be a problem. Before, during and
after surgery, the patient is given im
munosuppressive drugs, drugs which
suppress the body’s natural tendency to
attack foreign substances (in this case,
the transplanted kidney). But in suppres
sing the immune system so the body can
keep the kidney, the body is less able to
fight off any invading germs, thus becom
ing much more vulnerable to infection.
“That’s why reaching the precise level of
immunosuppression remains such a chal
lenge,” Dr. Stevens points out.
Some rejection episodes can be re
versed by temporarily increasing the
dosage of immunosupressive drugs. That
was the fortunate denouement of that
scene with Denise Chasten in the hospi
tal’s intensive care unit. She was able to
keep her kidney. If a rejection episode
cannot be reversed, the patient returns to
dialysis and may opt for another trans
plant later on.
Because Blacks statistically do less
well after transplantation than whites, the
Howard center has evolved some special
modes of treatment to deal with this prob
lem, Dr. Callender explains. Before a
transplant operation, a patient’s kidneys
may be removed to control hypertension
(far more prevalent amongst Blacks than
whites). The spleen also may be removed
to raise a patient’s white blood count
(which is generally lower in Blacks than
whites) so that the use of immunosup
pressive drugs is less likely to cause in
fection and to raise his platelet count so
there is less chance of excessive bleed
ing. Because the center also has found
that Blacks tend to tolerate steroid anti
rejection drugs less well than whites, it
makes greater use of the non-steroid
drug, antilymphocyte globulin, to fight re
jection than do centers treating predomi
nantly white patients.
Once a patient has been operated on
successfully, he continues to be closely
NEW DIRECTIONS APRIL 1984
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G od Should Have
the Glory’
monitored for signs of rejection and infec
tion. He or she also must learn to cope
with a new identity as a transplant recip
ient. And this is where the center’s regu
lar Thursday morning therapy sessions
play such an important role.
Group Therapy
These sessions bring together those
who are awaiting transplants, those who
have had successful transplants, those
who have been rehospitalized following
complications with their transplants and
sometimes family members of those in
each category.
One recent Thursday, a dialysis patient
awaiting transplant told of his yearning for
that which most people take for granted:
a glass of water. (Patients on dialysis
must severely restrict their fluid intake.)
Some who have had transplants worried
aloud about one of the side effects of their
anti-rejection medications: bone deteri
oration. A father of a patient awaiting a
transplant spoke of the way his son’s frus
tration caused him to lash out at every
one, while a patient who already had re
ceived a transplant told of how she once
had interpreted her family’s concern for
her health as an attempt to smother her.
“One of the main problems transplant
recipients face,” says social worker Earlene Reavies, “is that at some point they
forget that the kidney is not theirs, that
they weren’t born with it, that if they stop
taking their medicine, they’re going to re
ject. It’s a psychological step they go
through. So you have to remind them that
the kidney is not theirs.” She’s also found
that sometimes patients have trouble ad
justing to a more normal lifestyle after
being dependent on dialysis for a long
time or that they refuse to listen to “the
bad stuff” about transplants so when
something goes wrong, even though
they’ve been told all the risks, they feel
betrayed. Then there is all the anxiety
NEW DIRECTIONS APRIL 1984
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hen Dr. Clive Callender fin
ishes a successful opera
tion, his face lights up with
ju b ilatio n , e ra sin g th e
fatigue etched around his eyes and mak
ing his short crop of greying hair look as
if it must belong to someone else.
Yet the boyish-looking demeanor of
the nationally-recognized tran sp lan t
surgeon seem s to m ask a complex,
driven and often enigmatic personality.
He tells you of some of the dismal events
of his childhood— his m other dying during a home delivery when
he and his twin brother were coming into the world, a year spent
in a foster home, a year and a half spent in a hospital with tuber
culosis — and then says, “None of those things really bothered
m e.” He’s on the phone, laughing uproariously and exchanging
anecdotes about his favorite basketball team, the Bullets, and
later switches gears to speak in spiritual tones about the profound
impact religion has had on his life.
He admits that to work as hard as he does is “insanity, ” that he’s
surprised he’s not dead because of the abuse his body has taken
from his hectic schedule, and then tells his secretary to make a
plane reservation for him fo r tonight because he has to go back to
the Virgin Islands to check on a patient. He tells you he’s already
achieved his childhood dreams — to be a doctor and to serve in
Africa — and now feels he has “no more miles to conquer” and
then enthusiastically shares his hope that the Howard University
Hospital Transplant Center become a national referral center for
Black transplant patients, that it open its doors to Black patients
from all over the nation and the world, that it go into other types of
tran sp lan ts.. . .
The man at the center of these contrasts was born in Harlem 48
years ago. There he and his twin brother were raised by a dedi
cated and devout aunt following the death of their mother, the
rem arriage of their father to a woman whose own problems made
childrearing impossible and that year-long stay in a foster home.
(Carl Callender is a prominent New York attorney and minister.
That the two brothers have become Harlem success stories in
stead of Harlem casualties, Dr. Callender attributes to two fac
tors: “our aunt and our religious background. ”)
Dr. Callender says he decided to become a doctor when he was
seven. “One day in church something the m inister said struck a
chord, ” he recalls. “He said, ‘The best way you could serve man-
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kind was to minister to the body and soul of mankind.’ And I
thought I could best do that by becoming a doctor. ” Why would a
seven-year-old be concerned with something as lofty as “minister
ing to the body and soul of mankind?” “I thought that was the
ultimate thing to do with your life, ” he answ ers as if it was the
most obvious thing in the world, something any dummy would
know.
Among the landmarks along his journey to fulfilling his child
hood dream of a medical career: Hunter College in New York;
M eharry Medical College, where he finished first in his class;
Howard University’s Freedm en’s Hospital, where he did his resi
dency in surgery; Port Harcourt General Hospital in eastern
Nigeria, where he was a consultant in surgery; the University of
Minnesota, where he received advanced training in transplant
surgery; Howard University, to which he returned after that train
ing and where he now is not only director of the transplant center
but vice chairman of the departm ent of surgery in the hospital and
college of medicine; St. Thomas Hospital in St. Thomas, the U.S.
Virgin Islands, which has named its transplant center in his honor
for his work in making transplants available to the local populace.
Dr. Callender says he was initially attracted to transplant
surgery because “it was a new and challenging field. ” Through the
years, he estim ates, he’s been involved in betw een 400 and 500
kidney transplant operations. Through the years, too, he’s re
ceived so many awards and honors, participated in so many pro
fessional organizations, made so many presentations in so many
varied settings, authored or co-authored so many research papers
that his curriculum vitae runs to 27 closely-typed pages.
Yet he seem s uncomfortable in the limelight (“shy” is the word
one of the cen ter’s secretaries uses to describe him) and tries to
deflect all the praise that has come his way for the successful
transplants he’s performed. For one, he emphasizes, the trans
plant effort is a team effort with many people contributing their
expertise and concern. For another, he jokes, “I don’t like too
much praise because if you can get too much praise, you can get
too much criticism — and I don’t like th at.” But th ere’s another
reason and it’s a reason that relates to the depth of his religious
beliefs:
“I do what I know how to do. I put a kidney in and draw on my
knowledge and training to do the best job I possibly can. But
w hether the transplant is successful or not is not up to me. It’s up
to God. I tell my patients w e’ll do all we possibly can but I also tell
them that God is the final arbiter. And we ask them to pray that
God will direct us and guide us because I’ve always felt that in all
things God should have the glory. ”
□
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that can build up as they wonder if a
transplanted kidney will fail and “the
stages of depression and loss and mourn
ing” they go through if it does.
The Thursday morning sessions are
the place where transplant patients feel
free to drop the masks they wear out in
the world and reveal their innermost
feelings about what is bothering them. It’s
also the place where they can join to
gether to grope for solutions to common
problems. The sessions serve to further
patient education as well.
“The key to the whole thing in trans
plantation is self-care,” says Patricia Dil
lard, nursing supervisor for the center.
“We do whatever we have to do. We con
nect the kidney. We adjust the medica
tions. But if the patients are sent out
without a good understanding of what’s
going on from point A on, we can’t even
think about success. The patient has to
understand that if he misses one dose of
prednisone [an immunosuppressive] that
could mean he could reject— not just be
cause we say so, but because he under
stands transplants. He understands that
a, b, c, d are the signs of rejection so
therefore if he doesn’t take his prednisone
which has a, b, c, d side effects then he
has a chance to reject his kidney. ”
Indeed, as a result of the group therapy
sessions, even those patients with limited
formal education speak knowledgeably
about platelets, white blood counts, ALG
(antilympocyte globulin), creatinine. . .
Public Education and Advocacy
While the group therapy sessions reflect
the center’s goal to have “an informed pa
tient and an informed family,” as trans
plant coordinator Yeager puts it, the cen
te r’s staff also has been involved in a
larger educational effort: to spread the
word about the importance of organ
transplantation and donation and to en
courage more people, especially Black
NEW DIRECTIONS APRIL 1984
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people, to will their organs after death.
A Gallup Poll commissioned by the Na
tional Kidney Foundation found that 95
percent of whites were knowledgeable
about organ transplantation, compared to
84 percent of Blacks and that while 27
percent of whites were willing to donate
their organs after death, only 10 percent
of Blacks were willing to do so. A National
Kidney Foundation of the National Capital
Area press release also noted that in the
District of Columbia, where 70 percent of
the kidney patients are Black, fewer than
20 percent of the donors are Black.
One preliminary study conducted by
Howard University researchers found
that the most common reason Black re
spondents gave for not willing their or
gans was lack of information. This, in
turn, made many superstitious.
Some expressed fears about being cut
up after death. (Dr. Callender’s response
to this fear: “Everybody gets cut up after
death — unless they get cremated. If
you’re going to be embalmed, they cut
you up anyway. Besides, after you’re
dead you don’t have any pain. ”)
Some were afraid they wouldn’t be able
to “get into heaven” if their bodies were
not com pletely intact. (Again, Dr.
Callender’s response is to cite the em
balming procedure, adding, “So you’re
not going intact anywhere [after death]. ”)
Then there were those who expressed
apprehension that if they will their or
gans, when they are sick in a hospital they
will not receive proper care because the
doctors will be so eager to pluck out their
organs and give them to someone else.
(Dr. Callender’s answer: “Basically, the
doctors who determine whether you’re
alive or dead neurologically are com
pletely separate from those doctors who
are going to do transplants. That separa
tion should always exist. ”)
Dr. Callender currently serves as
chairman of the D.C. Organ Donor Proj
ect, a pilot project supported by the Na
tional Kidney Foundation, which aims to
help Black Washingtonians overcome
their reluctance to donate kidneys. The
project includes conducting an education
campaign through the Bureau of Motor
Vehicle Services in which drivers seeking
licenses are given information about
organ donation and given the option of
having their licenses stamped on the spot
if they wish to be classified as donors. It
also includes developing and implement
ing a lesson plan for the D.C. public
http://dh.howard.edu/newdirections/vol11/iss3/2
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schools that covers organ donation and discriminated against because they don’t
utilizing the media and community meet have the funds,” Dr. Callender observes.
ings to spread the word about its im “Liver transplants are not covered by
portance.
Medicare so most of the white folks who
have
transplants raise funds. It’s easy to
For the Howard center’s staff, the ra
figure
out that it’s much easier for a white
tionale for such an educational project is
person
to raise funds among whites for a
self-evident. Says Dr. Callender, who has
liver
transplant
than for a Black person to
signed an organ donor card himself: “Here
raise
funds
among
Blacks for one. If a
we are in the District of Columbia, which
Black
person
goes
to
his friends, he might
has the highest incidence of renal disease
raise
$200
or
$1,000.
But when we talk
in the nation, so it seems to make sense
about
a
liver
transplant,
we’re talking
to leave our organs behind when we die so
about
$50,000
to
$100,000.”
that other Blacks who suffer from this af
As he looks to the future of the Howard
fliction could have an improved quality of
life. We talk about doing things to help University Hospital Transplant Center,
each other, so here is the greatest time to Dr. Callender also envisions it evolving
h e lp ... After you die, you’re not going to into a referral and treatment center for
Black transplant patients from all over the
use your organs anyway. ”
nation.
Not only has Dr. Callender and his staff
It seems an overreaching dream. But
been involved in bringing the transplanta
then,
again, so did the whole notion of
tion perspective to Blacks, but they also
kidney
transplantation, itself, at one
have been instrumental in bringing the
time.
That
the dream is now a reality is
Black perspective to transplantation. In
something
for which the Scottie LeftCongressional and other testimony, Dr.
dwriges
of
this
world are most grateful.
Callender has warned that most minority
Amen.
□
persons cannot afford cyclosporin A, a
major new anti-rejection drug that is
being hailed as a breakthrough in trans
plantation. (The drug costs approxi
mately $5,000 a year and is not covered
by Medicare as is true for all out-of
hospital transplant medications. So if one
is not eligible for Medicaid, one would
have to foot this hefty bill.)
He also has spoken out against the en
tire idea of organ selling. (Several bills
have been introduced into Congress to
ban this most controversial variant of
“free enterprise.” Efforts to get such a
bill passed came after widespread public
ity about a Reston, Va. man’s intent to
open a profit-making organ brokerage
firm.)
“Selling organs is the worst thing that
could happen to transplant surgery, ” says
Dr. Callender, with vehemence. “What
would happen is that Blacks — again —
would be victimized. Someone would say
to some Black guy, 'Here’s $20,000 for
your kidney so we can give it to someone
else.’ It is my belief that organ selling
would result in the socioeconomicallydeprived groups being abused arid for that
reason I am as strongly opposed to it as I
could possibly be.”
Concern with the victimization of
minorities also has fueled the center’s in
terest in doing liver transplants. “We
hope to be able to offer liver transplanta
tion to minorities who, at this point, are
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